A study of the dual pathways that process the essential vitamin folate unexpectedly revealed a new way the cancer drug methotrexate works and may suggest strategies to boost its cancer-killing effects.
Weill Cornell Medicine has been awarded a five-year, $9 million Program Project Grant from the National Cancer Institute to study an aggressive and incurable form of lymphoma.
This year's AAAS electees from Cornell include a renowned artificial intelligence researcher, an emeritus professor who studies animal migration patterns, and a food safety expert.
Global Grand Challenges Symposium brought together faculty, administrators and guests to discuss challenges on which Cornell should place emphasis and resources in 2019-2020.
World experts in neurodegenerative diseases gathered at Weill Cornell Medicine Sept. 25 to present the latest discoveries in the study and treatment of Alzheimer's disease.
Cross-campus gathering will focus on the biggest challenges facing the world, and help determine a theme on which the university will focus in the 2019-2020 academic year.
As therapies for HIV have advanced to help many patients control the infection as a chronic disease, investigators and patients have set their sights on a new goal: finding a cure. Drs. Douglas Nixon and Brad Jones have recently joined Weill Cornell Medicine in the hopes of accelerating that hunt.
Ultrasmall Cornell dots armed with antibodies are another weapon in the fight against cancer, says Uli Wiesner, professor of materials science and engineering.
The Sept. 27-28 symposium “Bridging the Divide: Machine Learning in Medicine,” held at the Cornell Lab of Ornithology, brought together researchers and clinicians from Cornell’s Ithaca campus and Weill Cornell Medicine to discuss recent work and initiate collaborations in the field of machine learning in medicine.
